Science Grants Reviewed Behind Closed Doors
Published Date: 5/27/2025
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings in late June 2025 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding to explore health and science topics. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 0 costs, 1 mixed.
NIH Grant Reviews Scheduled June 23-27
The NIH Center for Scientific Review will hold several closed virtual meetings from June 23 through June 27, 2025 (meetings run at various times between about 8:00 a.m. and 8:00 p.m. ET) to review and decide on grant applications. If you are a researcher who applied for NIH funding, these meetings determine funding decisions for those applications.
Applicant Confidentiality Protected
The meetings will be closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) because grant applications may disclose confidential trade secrets, patentable material, or personal information. This protects applicants' commercial and personal information during peer review.
Virtual Format Means No Travel Cost
All listed review meetings are designated as virtual meetings (for example, committees meet June 23-26 and June 26-27, 2025). Researchers applying for grants will not need to attend in person, so there is no public attendance and no additional travel cost tied to these meetings.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14966, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a new Ebola vaccine invention for companies to license and develop quickly. This vaccine targets the Bundibugyo virus and promises fast and lasting protection, helping stop outbreaks in Central Africa. Businesses interested in licensing should act soon to bring this life-saving tech to market and can contact NIH for details.
Previous / Next Documents
Previous: 2025-09383, International Standard-Setting Activities
Heads up to food producers, traders, and safety fans! The government is sharing updates on international food safety and quality rules set by Codex from June 2024 to May 2026. They want your thoughts on current and new standards to keep our food safe and fair—no cost changes yet, just your input by the deadlines.
Next: 2025-09386, Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Acid Rain Program Under Title IV of the Clean Air Act Amendments (Renewal)
The EPA is asking to keep collecting info for the Acid Rain Program, which helps control pollution from power plants. This affects companies that produce acid rain-causing emissions and keeps the program running smoothly without extra costs. They’re giving the public 30 more days to share thoughts before final approval, with the current approval ending May 31, 2025.